Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Large And Small-Scale Bioprocessing Market Expected To Become By 2029 Compared With Its 2025 Level?
The large and small-scale bioprocessing market has experienced rapid expansion in recent years. It is projected to grow from $59.63 billion in 2024 to $67.66 billion in 2025, at a compound annual growth rate (CAGR) of 13.5%. The market’s past growth is attributable to the expansion of the medical industry, the establishment of regulatory standards, ongoing technological advancements, the development of the pharmaceutical and biotechnology sectors, and increasing food safety concerns.
The large and small-scale bioprocessing market is projected to experience substantial growth over the coming years. It is anticipated to expand to $108.81 billion by 2029, achieving a compound annual growth rate (CAGR) of 12.6%. This projected growth is driven by factors such as increasing healthcare expenditure, the widening scope of the pharmaceutical and biotechnology sectors, technological advancements, evolving regulatory requirements, heightened awareness of food safety, and the ongoing effects of the COVID-19 pandemic. Significant developments expected during this forecast period involve the integration of advanced technologies, expansion into new regions, the outsourcing of sterilization services, the implementation of sustainable practices, the use of hybrid sterilization techniques, and the provision of customized sterilization solutions.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15845&type=smp
Which Drivers Are Supporting Growth Of The Large And Small-Scale Bioprocessing Market?
The increasing need for biologics is anticipated to drive the expansion of the large and small-scale bioprocessing market in the future. Biologics are defined as therapeutic items originating from living organisms or their constituent parts, encompassing vaccines, blood and its components, gene therapies, various tissues, and engineered therapeutic proteins. This rising demand for biologics stems from progress in biotechnology, an improved comprehension of how diseases function, and the desire for highly specific and individualized treatments. Both large-scale and small-scale bioprocessing methods are crucial for the effective development and subsequent market introduction of biologics. Small-scale bioprocessing plays a vital role in the initial phases of development, process refinement, and assessing viability. Conversely, large-scale bioprocessing guarantees the production of biologics in an efficient, uniform manner, adhering to regulatory mandates for widespread commercial release. For example, data from February 2024, sourced from the US-based medical library, the National Library of Medicine, indicated that in 2023, the Food and Drug Administration (FDA) authorized 55 new drugs. This total included 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), representing a substantial 50% increase over the 37 approvals recorded in 2022. Consequently, the increasing need for biologics is a key factor propelling the expansion of the large and small-scale bioprocessing market.
What Are The Emerging Segments Gaining Attention In The Large And Small-Scale Bioprocessing Market?
The large and small-scale bioprocessingmarket covered in this report is segmented –
1) By Product: Bioreactors Or Fermenters; Cell Culture Products; Filtration Assemblies; Bioreactors Accessories; Bags And Containers; Other Products
2) By Mode: In-house; Outsourced
3) By Workflow: Downstream Processing; Fermentation; Upstream Processing
4) By Scale: Industrial Scale; Small Scale
5) By Application: Biopharmaceuticals; Specialty Industrial Chemicals; Environmental Aids
Subsegments:
1) Bioreactors Or Fermenters: Single-Use Bioreactors; Stainless Steel Bioreactors; Glass Bioreactors
2) Cell Culture Products: Cell Culture Media; Sera And Supplements; Reagents
3) Filtration Assemblies: Membrane Filters; Depth Filters; Tangential Flow Filtration Systems
4) Bioreactor Accessories: Spargers; Impellers; Sensors And Probes
5) Bags And Containers: Single-Use Bags; Storage Containers; Transfer Bags
6) Other Products: Mixers; Tubing And Connectors; Sampling Systems
What Trends Are Expected To Drive The Large And Small-Scale Bioprocessing Market?
Leading companies in the large and small-scale bioprocessing sector are innovating products like single-use centrifuge systems to better equip customers with advanced capabilities. These single-use centrifuge systems are disposable, pre-sterilized centrifugation apparatus engineered for isolating biological substances within bioprocessing applications. For example, in September 2022, Thermo Fisher Scientific Inc., a US-based biotechnology company, unveiled the DynaSpin Single-Use Centrifuge system. This system is intended to optimize large-scale cell culture harvesting by streamlining the separation process, thereby reducing the necessity for multiple depth filtration cartridges and providing advantages such as enhanced product yield, improved operational efficiency, cost reductions, and environmentally friendly practices in biologics manufacturing. The DynaSpin system aids in minimizing production costs and advancing sustainability targets by notably lowering material consumption and waste compared to conventional harvest systems.
Who Are The Core Companies Influencing The Large And Small-Scale Bioprocessing Market Landscape?
Major companies operating in the large and small-scale bioprocessing market are F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, 3M Company, Takeda Pharmaceutical Company Ltd., Danaher Corporation, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Becton Dickinson and Company (BD), Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company, Lonza Group, Sun Pharmaceutical Industries Ltd., GE Healthcare Life Sciences, Sartorius AG, Dr. Reddy’s Laboratories Ltd., Alkem Laboratories Limited, Piramal Enterprises Ltd
Download The Full Report For Exclusive Market Findings:
Which Global Regions Are Influencing The Competitive Landscape Of The Large And Small-Scale Bioprocessing Market?
North America was the largest region in the large and small-scale bioprocessing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large and small-scale bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Large And Small-Scale Bioprocessing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15845&type=smp
Browse Through More Reports Similar to the Global Large And Small-Scale Bioprocessing Market 2025, By The Business Research Company
Single Use Bioprocessing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/single-use-bioprocessing-global-market-report
Bioprocessing Technology Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bioprocessing-technology-global-market-report
Large Scale Natural Refrigerant Heat Pump Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model